An­oth­er one of Neil Wood­ford's port­fo­lio com­pa­nies es­capes as UK biotech ex­ecs flee a col­lapse of faith

LON­DON — Ma­lin has joined the grow­ing queue of life sci­ences com­pa­nies that have man­aged to ex­tri­cate them­selves from a flail­ing Neil Wood­ford.

The biotech in­vest­ment group $MLC not­ed in a re­lease that Pent­wa­ter Cap­i­tal — a US hedge fund — had boost­ed its hold­ings in the com­pa­ny to 26%, tak­ing out a large por­tion of the stake that was held by a deeply trou­bled Wood­ford In­vest­ment Man­age­ment, which now holds less than 3% of the stock.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER